Jiangsu Lianhuan Pharmaceutical Co (SHSE:600513) Total Liabilities : ¥1,276 Mil (As of Mar. 2024)

View and export this data going back to 2003. Start your Free Trial

What is Jiangsu Lianhuan Pharmaceutical Co Total Liabilities?

Jiangsu Lianhuan Pharmaceutical Co's Total Liabilities for the quarter that ended in Mar. 2024 was ¥1,276 Mil.

Jiangsu Lianhuan Pharmaceutical Co's quarterly Total Liabilities declined from Sep. 2023 (¥1,338.71 Mil) to Dec. 2023 (¥1,338.39 Mil) and declined from Dec. 2023 (¥1,338.39 Mil) to Mar. 2024 (¥1,275.75 Mil).

Jiangsu Lianhuan Pharmaceutical Co's annual Total Liabilities increased from Dec. 2021 (¥1,073.87 Mil) to Dec. 2022 (¥1,301.21 Mil) and increased from Dec. 2022 (¥1,301.21 Mil) to Dec. 2023 (¥1,338.39 Mil).

Jiangsu Lianhuan Pharmaceutical Co Total Liabilities Historical Data

The historical data trend for Jiangsu Lianhuan Pharmaceutical Co's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jiangsu Lianhuan Pharmaceutical Co Total Liabilities Chart

Jiangsu Lianhuan Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

Get a 7-Day Free Trial

805.57

869.58

1,073.87

1,301.21

1,338.39

Jiangsu Lianhuan Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Liabilities	Get a 7-Day Free Trial															1,257.29	1,319.69	1,338.71	1,338.39	1,275.75

Jiangsu Lianhuan Pharmaceutical Co Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Jiangsu Lianhuan Pharmaceutical Co's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	1246.521	+	(82.912	+	8.9590000000001
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	1,338

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	2855.702	-	1517.31
	=	1,338

Jiangsu Lianhuan Pharmaceutical Co's Total Liabilities for the quarter that ended in Mar. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	1184.031	+	(82.48	+	9.2339999999999
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	1,276

Total Liabilities	=	Total Assets (Q: Mar. 2024 )	-	Total Equity (Q: Mar. 2024 )
	=	2829.973	-	1554.228
	=	1,276

Jiangsu Lianhuan Pharmaceutical Co Total Liabilities Related Terms

Thank you for viewing the detailed overview of Jiangsu Lianhuan Pharmaceutical Co's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Jiangsu Lianhuan Pharmaceutical Co (SHSE:600513) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jiangsu Lianhuan Pharmaceutical Co Ltd (SHSE:600513) » Definitions » Total Liabilities

Traded in Other Exchanges

N/A

Address

No. 21 Wenfeng Road, Jiangsu Province, Yangzhou, Jiangsu, CHN, 225009

Website

http://www.lhpharma.com

Jiangsu Lianhuan Pharmaceutical Co Ltd is engaged in producing benign prostatic hyperplasia, allergy and cardiovascular drugs.

Executives

Chu Qing Song	senior management
Xia Chun Lai	Director
Pan He Ping	Directors, senior managers
Niu Ben	senior management
Wu Wen Ge	Director
Zhu Yong Jun	senior management
Qian Zhen Hua	Director
Shen Yi	senior management
Huang Wen Tao	senior management
Zhou Jun	senior management
Tu Bin	senior management
Qin Xiong Jian	senior management

Jiangsu Lianhuan Pharmaceutical Co (SHSE:600513) Headlines

No Headlines